Blog tagged as Healthcare

Imaging is essential to trials but remains one of the most broken workflows. Yunu CEO Jeff Sorenson shares how real-time, connected platforms improve accuracy, speed, and patient outcomes by replacing outdated imaging processes.

With over two decades of experience in clinical research and business development, Patrick McNamara has played a pivotal role in Yunu’s rapid expansion across the pharmaceutical, biotech, and contract research organization (CRO) sectors.

Emerging technologies are transforming pediatric oncology trials—boosting efficiency, protecting staff, and accelerating access to life-saving therapies through AI, real-world data, decentralized models, and digital tools.

This interview with Yunu CEO Jeffrey Sorenson explores how elevating imaging data in clinical trials can improve data integrity, trial efficiency, and patient outcomes, highlighting tech innovations and structural shifts needed for modern oncology research.

Yunu announces a major software release enabling pharma sponsors to configure studies in minutes, ensure imaging consistency, and deliver data directly to primary systems—while streamlining workflows for site staff.

Imaging plays a vital role in oncology trials, guiding how we track tumors and assess treatment success. But when trial sites vary in how they capture and interpret images, it can cloud the results. Learn why standardizing imaging is essential for clear, reliable insights in cancer research.

Yunu, provider of transformative clinical trials imaging workflow solutions, secured an investment led by Spring Mountain Capital, affirming Yunu’s position as an emerging category leader and proven innovator within the clinical trial imaging market.

Yunu, creator of the industry’s first end-to-end clinical trial imaging workflow platform supporting sites, CROs and pharma, was proud to sponsor the 2025 HCI Frontiers Symposium’s NextGen Scientist Awards.

This blog explores the critical need for consistency, collaboration, and tailored imaging approaches in multi-center trials. Learn how technology and standardization can improve imaging accuracy, streamline workflows, and enhance outcomes for patients.

Discover the critical role of an oncology clinical trial Principal Investigator (PI) in patient care, collaboration, & trial management. Explore the challenges, responsibilities, and impact of PIs in advancing cancer research while ensuring accuracy, compliance, and innovation in clinical trials.

Dr. Harris, who has spent years at the forefront of imaging research at institutions like the Dana-Farber/Harvard Cancer Center and MGH, shared eye-opening insights into why clinical trial imaging is often broken and, more importantly, how Yunu is working to fix it.

Dr. Scott Bradfield, pediatric oncologist and clinical trial PI, brings insights as Yunu's Medical Advisor. His role bridges pediatric cancer research, patient care, and technology, offering valuable perspectives on clinical trial challenges and opportunities.

Yunu is pleased to announce its partnership with WCG, a global leader in clinical trial solutions, in support of WCG’s imaging services.

Yunu is pleased to announce its partnership with WCG, a global leader in clinical trial solutions, in support of WCG’s imaging services.

McNamara’s extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies, brings a wealth of expertise to accelerate Yunu’s life sciences business.

A recent panel podcast on The Imaging Accuracy Crisis in Clinical Trials brought to light critical issues and innovative solutions that are reshaping the landscape of clinical trials.

Yunu is pleased to announce that it will extend the free use of its platform for all Children’s Oncology Group (COG) clinical trials nationwide.

The clinical trial landscape faces significant challenges impacting financial outcomes and patient well-being, with clinical trial imaging errors being among the most pressing issues. These errors can lead to substantial monetary losses and skewed trial results for trial sponsors.